Point72 Middle East FZE’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,344
Closed -$1.61K 2183
2023
Q1
$1.61K Sell
1,344
-5,581
-81% -$12.4K ﹤0.01% 1547
2022
Q4
$9.83K Buy
+6,925
New +$14.9K ﹤0.01% 1729

Other funds holding DBD

Point72 Middle East FZE's DBD Position: Q2 2023 in Review

Point72 Middle East FZE sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 1,344 shares — an estimated $1.61K sold.

Point72 Middle East FZE first reported a position in DBD in Q4 2022 and held it in 2 quarters. The position peaked at $9.83K in Q4 2022. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

  • Point72 Middle East FZE reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 1,344 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $1.61K.
  • Point72 Middle East FZE first reported a position in Diebold Nixdorf Incorporated in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's Diebold Nixdorf Incorporated position peaked at $9.83K in Q4 2022.
  • 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.